The clinical management in extremely severe COPD

Respiratory Medicine

Volumn 101, Issue 8, 2007, Pages 1613-1624

  Ambrosino, Nicolino ^a   Simonds, Anita ^b  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

COPD; Dyspnoea; End of life; Exercise; Mechanical ventilation

Indexed keywords

ANXIOLYTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FUROSEMIDE; LONG ACTING DRUG; METHADONE; MORPHINE; OPIATE DERIVATIVE; OXYGEN; PLACEBO; RESPIRATORY TRACT AGENT; STEROID;

ARTIFICIAL VENTILATION; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CLINICAL TRIAL; COGNITION; DEPRESSION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FINANCIAL MANAGEMENT; HEALTH CARE SYSTEM; HUMAN; HYPERCAPNIA; HYPOXEMIA; LONG TERM CARE; LUNG TRANSPLANTATION; META ANALYSIS; MORBIDITY; MORTALITY; NON INVASIVE PROCEDURE; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PALLIATIVE THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY REHABILITATION; QUALITY OF LIFE; RECIPIENT; REVIEW; SYSTEMATIC REVIEW;

AGE FACTORS; DYSPNEA; EXERCISE; HUMANS; PATIENT EDUCATION AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; VENTILATORS, MECHANICAL;

EID: 34250753927     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.02.011     Document Type: Review

References (146)

1. Field M.J., and Cassel C.K. Approaching death: improving care at the end of life Institute of Medicine Report (1997), National Academy Press, Washington, DC
2. Global initiative for chronic obstructive lung disease. Workshop report, global strategy for diagnosis, management, and prevention of COPD. Update September 2005. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute; 2005. Available from: 〈www.goldcopd.com〉.
3. Celli B.R., MacNee W., Agusti A., Anzueto A., Berg B., Buist A.S., et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
4. Simonds A.K. Care of end stage lung disease. Breathe 4 (2006) 315-320
5. Mannino D.M. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121 (2002) 121S-126S
6. Hoogendoorn M., Feenstra T.L., Shermer T.R.J., Hesselink A.E., and Rutten Van Molken M.P.M.H. Severity distribution of chronic obstructive pulmonary disease in Dutch general practice. Respir Med 100 (2006) 83-86
7. Stenfors N. Physician-diagnosed COPD Global Initiative for Chronic Obstructive Lung Disease Stage IV in Östersund, Sweden. Patient characteristics and estimated prevalence. Chest 130 (2006) 666-671
8. Zielinski J., Bednarek M., Gorecka D., Viegi G., Hurd S.S., Fukuchi Y., et al. Increasing COPD awareness. Eur Respir J 27 (2006) 833-852
9. Menezes A.M., Perez-Padilla R., Jardim J.R., Muino A., Lopez M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 366 (2005) 1875-1881
10. Mannino D.M., Reichert M.M., and Davis K.J. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 173 (2006) 985-990
11. Mannino D.M., Doherty D.E., and Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 100 (2006) 115-122
12. Martinez F.J., Foster G., Curtis J.L., Criner G., Weinmann G., Fishman A., et al., for the NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173 (2006) 1326-1334
13. Machado M.L., Krishnan J.A., Buist S.A., Bilderback A.L., Fazolo G.P., Santarosa M.G., et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174 (2006) 524-529
14. Kinnunen T., Saynajakangas O., and Keistinen T. The COPD-induced hospitalization burden from first admission to death. Respir Med 101 (2007) 294-299
15. Connors Jr. A.F., Dawson N.V., Thomas C., Harrell Jr. F.E., Desbiens N., Fulkerson W.J., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med (1996) 959-967
16. Gunen H., Hacievliyagil S.S., Kosar F., Mutlu L.C., Gulbas G., Pehlivan E., et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J 26 (2005) 234-241
17. Vitacca M., Bianchi L., Barbano L., Ziliani M., and Ambrosino N. Effects of acute on chronic respiratory failure on hypercapnia and 3-month survival. Chest 128 (2005) 1209-1215
18. Groenewegen K.H., Schols A.M.W.J., and Wouters E.F.M. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124 (2003) 459-467
19. Simonds A.K. Outcome of mechanical ventilation in acute exacerbations of COPD. Living and dying with respiratory failure: facilitating decision making. Chron Respir Dis 1 (2004) 56-59
20. Rivera-Fernandez R., Navarrete-Navarro P., Fernandez-Mondejar E., Rodriguez-Elvira M., Guerrero-Lopez F., and Vazquez-Mata G. Project for the Epidemiological Analysis of Critical Care Patients (PAEEC) Group Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med 34 (2006) 2317-2324
21. Agusti A.G.N. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 367-370
22. Rennard S.I. Clinical approach to patients with chronic obstructive pulmonary disease and cardiovascular disease. Proc Am Thorac Soc 2 (2005) 94-100
23. Schunemann H.J., Dorn J., Grant B.J., Winkelstein Jr. W., and Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118 (2000) 656-664
24. Chaouat A., Bugnet A.S., Kadaoui N., Schott R., Enache I., Ducolone A., et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172 (2005) 189-194
25. Pinto-Plata V.M., Mullerova H., Toso J.F., Feudjo-Tepie M., Soriano J.B., Vessey R.S., et al. C-reactive protein in patients with COPD, control smokers, and nonsmokers. Thorax 61 (2006) 23-28
26. Koechlin C., Maltais F., Saey D., Michaud A., LeBlanc P., Hayot M., et al. Hypoxemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 60 (2005) 834-841
27. Agusti A.G., Sauleda J., Miralles C., Gomez C., Togores B., Sala E., et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 485-489
28. Montes de Oca M., Torres S.H., De Sanctis J., Mata A., Hernández N., and Tálamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 26 (2005) 1-8
29. Restrick L.J., Paul E.A., Braid G.M., Cullinan P., Moore-Gillon J., and Wedzicha J.A. Assessment and follow up of patients prescribed long term oxygen therapy. Thorax 48 (1993) 708-713
30. Gore J.M., Brophy C.J., and Greenstone M.A. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 55 (2000) 1000-1006
31. Claessens M.T., Lynn J., Zhong Z., Desbiens N.A., Phillips R.S., Wu A.W., et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc 48 (2000) S146-S153
32. Anthonisen N.R., Skeans M.A., Wise R.A., Manfreda J., Kanner R.E., and Connett J.E. The effects of a smoking cessation intervention on 14.5- year mortality: a randomized clinical trial. Ann Intern Med 142 (2005) 233-239
33. Report of British Research Medical Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complication in chronic bronchitis and emphysema. Lancet i (1981) 681-686
34. Cranston J.M., Crockett A.J., Moss J.R., and Alpers J.H. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4 (2005) CD001744
35. Kiri V.A., Pride N.B., Soriano J.B., and Vestbo J. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Am J Respir Crit Care Med 172 (2005) 460-464
36. Macie C., Wooldrage K., Manfreda J., and Anthonisen N.R. Inhaled corticosteroids and mortality in COPD. Chest 130 (2006) 640-646
37. Sin D.D., Wu L., Anderson J.A., Anthonisen N.R., Buist A.S., Burge P.S., et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 60 (2005) 992-997
38. Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, et al. for the TORCH investigators. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 2007;356:775-789.
39. Cano N.J.M., Pichard C., Eng H.R., Court-Fortuné I., Cynober L., Gérard-Boncompain M., et al. and the Clinical Research Group of the Société Francophone de Nutrition Entérale et Parentérale C-Reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 126 (2004) 540-546
40. van Helvoort H.A.C., Heijdra Y.F., Heunks L.M.A., Meijer P.L.M., Ruitenbeek W., Thijs H.M.H., et al. Supplemental oxygen prevents exercise-induced oxidative stress in muscle-wasted patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 173 (2006) 1122-1129
41. Croxton T.L., Bailey W.C., and for the NHLBI Working Group. Long-term oxygen treatment in COPD long-term oxygen treatment in chronic obstructive pulmonary disease: Recommendations for future research: an nhlbi workshop report. Am J Respir Crit Care Med 174 (2006) 373-378
42. Guyatt G.H., Nonoyama M., Lucchetti C., Goeree R., McKim D., Heels-Ansdell D., et al. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med 172 (2005) 573-580
43. Hanania N.A., Ambrosino N., Calverley P., Cazzola M., Donner C.F., and Make B. Treatments for COPD. Respir Med 99 Suppl. 2 (2005) S28-S40
44. Muir J.F., Cuvelier A., and Tenang B. European task force on mechanical ventilation COPD. Long-term home nasal intermittent positive pressure ventilation (NIPPV) plus oxygen therapy (LTOT) versus LTOT alone in severe hypercapnic COPD. Preliminary results of a European multicentre trial. Am J Respir Crit Care Med 155 (1997) A408
45. Clini E., Sturani C., Viaggi S., Corrado A., Donner C.F., Rossi A., et al. The Italian multicentric study on non invasive ventilation in COPD patients. Eur Resp J 20 (2002) 529-538
46. Garrod R., Mikelsons C., Paul E.A., and Wedzicha J.A. Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162 (2000) 1335-1341
47. Garcia-Aymerich J., Lange P., Benet M., Schnohr P., and Anto J.M. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61 (2006) 772-778
48. Mercken E.M., Hageman G.J., Schols A.M., Akkermans M.A., Bast A., and Wouters E.F. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172 (2005) 994-1001
49. Nici L., Donner C., Wouters E., Zu wallack R., Ambrosino N., et al., on behalf of the ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173 (2006) 1390-1413
50. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
51. Cote C.G., and Celli B.R. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26 (2005) 630-636
52. Porta R., Vitacca M., Gilè L.S., Clini E., Bianchi L., Zanotti E., et al. Supported arm training in patients recently weaned from mechanical ventilation. Chest 128 (2005) 2511-2520
53. Clini E., and Ambrosino N. Early physiotherapy in the respiratory intensive care unit. Respir Med 99 (2005) 1096-1104
54. Martin U.J., Hincapie L., Nimchuk M., Gaughan J., and Criner G.J. Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation. Crit Care Med 33 (2005) 2259-2265
55. Ambrosino N., and Strambi S. New strategies to improve exercise tolerance in COPD. Eur Resp J 24 (2004) 313-322
56. Bianchi L., Foglio K., Pagani M., Vitacca M., Rossi A., and Ambrosino N. Effects of proportional assist ventilation on exercise tolerance in COPD patients with chronic hypercapnia. Eur Resp J 11 (1998) 422-427
57. Ambrosino N. Assisted ventilation as an aid to exercise training: a mechanical doping?. Eur Respir J 27 (2006) 3-5
58. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume reduction surgery. N Engl J Med 345 (2001) 1075-1083
59. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 (2003) 2059-2073
60. Hopkinson N.S., Toma T.P., Hansell D.M., Goldstraw P., Moxham J., Geddes D.M., and Polkey M.I. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 171 (2005) 453-460
61. Pierson R.N.3r. Lung transplantation: current status and challenges. Transplantation 81 (2006) 1609-1615
62. Ambrosino N., Bruschi C., Callegari G., Baiocchi S., Felicetti G., Fracchia C., et al. Time course of exercise capacity, and skeletal and respiratory muscle performance after heart-lung transplantation. Eur Respir J 9 (1996) 1508-1514
63. Gay S.E., and Martinez F.J. Pulmonary rehabilitation and transplantation. In: Donner C.F., Ambrosino N., and Goldstein R.S. (Eds). Pulmonary rehabilitation (2005), Arnold, London 304-311
64. Martinez F.J., and Chang A. Surgical therapy for chronic obstructive pulmonary disease. Semin Respir Crit Care Med 26 (2005) 167-191
65. Landbo C., Prescott E., Lange P., Vestbo J., and Almdal T.P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1856-1861
66. Prescott E., Almdal T., Mikkelsen K.L., Tofteng C.L., Vestbo J., and Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 20 (2002) 539-544
67. Jee S.H., Sull J.W., Park J., Lee S.Y., Ohrr H., Guallar E., and Samet J.M. Body-mass index and mortality in Korean men and women. N Engl J Med 355 (2006) 779-787
68. McWhirter J.P., and Pennington C.R. Incidence and recognition of malnutrition in hospital. Br Med J 308 (1994) 945-949
69. Schols A.M.W.J., and Wouters E.F.M. Nutrition and metabolic therapy. In: Donner C.F., Ambrosino N., and Goldstein R.S. (Eds). Pulmonary rehabilitation (2005), Hodder Arnold, London 229-235
70. Debigarè R., Cote C.H., and Maltais F. Peripheral muscle wasting in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 164 (2001) 1712-1717
71. Wouters E.F.M. Chronic obstructive pulmonary disease. Systemic effects of COPD. Thorax 57 (2002) 1067-1070
72. Anthonisen N.R., Wright E.C., and Hodgkin J.E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 133 (1986) 14-20
73. Schols A.M., Slangen J., Volovics L., and Wouters E.F.M. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
74. Sivasothy P., Smith I.E., and Shneerson J.M. Mask intermittent positive pressure ventilation in chronic hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Eur Respir J 11 (1998) 34-40
75. Cano N.J., Roth H., Court-Ortune I., Cynober L., Gerard-Boncompain M., Cuvelier A., et al. Clinical Research Group of the Societe Francophone de Nutrition Enterale et Parenterale, on behalf of the Clinical research Group of the SFNEP. Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur Respir J 20 (2002) 30-37
76. Ambrosino N., and Clini E. Long-term mechanical ventilation and nutrition. Respir Med 98 (2004) 413-420
77. Vestbo J., Prescott E., Almdal T., Dahl M., Nordestgaard B.G., Andersen T., et al. Body mass, fat-free body mass, and prognosis in patients with Chronic Obstructive Pulmonary Disease from a random population sample findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173 (2006) 79-83
78. Schols A.M., Broekhuizen R., Weling-Scheepers C.A., and Wouters E.F. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82 (2005) 53-59
79. Chailleux E., Laaban J.P., and Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy. Data from the ANTADIR observatory. Chest 123 (2003) 1460-1466
80. Schols A.M.W.J., Soeters P.B., Mostert R., Pluymers R.J., and Wouters E.F.M. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152 (1995) 1268-1274
81. Burdet L., de Muralt B., Schutz Y., Pichard C., and Fitting J.W. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective randomized, controlled study. Am J Respir Crit Care Med 156 (1997) 1800-1806
82. Pingleton S.K. Enteral nutrition in patients with respiratory disease. Eur Respir J 9 (1996) 364-370
83. Hill N.S. Failure to wean. In: Fishman A.P. (Ed). Pulmonary rehabilitation (1996), Marcel-Dekker Inc, New York 577-617
84. Aubier M., Murciano D., and Lecocguic Y. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 313 (1985) 420-424
85. Ellis D.A. Intermediate metabolism of muscle in Duchenne muscular dystrophy. Br Med Bull 36 (1980) 165-171
86. Gronberg A.M., Slinde F., Engstrom C.P., Hulthen L., and Larsson S. Dietary problems in patients with severe chronic obstructive pulmonary disease. J Hum Nutr Diet 18 (2005) 445-452
87. Elpern E.H., Scott M.G., Petro L., and Ries M.H. Pulmonary aspiration in mechanically ventilated patients with tracheostomies. Chest 105 (1994) 563-566
88. Tolep K., Getch C.L., and Criner G.J. Swallowing dysfunction in patients receiving prolonged mechanical ventilation. Chest 109 (1996) 167-172
89. Vitacca M., Callegari G., Sarvà M., Bianchi L., Barbano L., Balbi B., et al. Physiological effects of meals in difficult-to-wean tracheostomised patients with chronic obstructive pulmonary disease. Intensive Care Med 31 (2005) 236-242
90. Anker S.D., John M., Pedersen P.U., Raguso C., Cicoira M., Dardai E., et al. ESPEN guidelines on enteral nutrition: cardiology and pulmonology. Clin Nutr 25 (2006) 311-318
91. Ferreira I.M., Brooks D., Lacasse Y., Goldstein R.S., and White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2 (2005) CD000998
92. Mallampalli A. Nutritional management of the patient with chronic obstructive pulmonary disease. Nutr Clin Pract 19 (2004) 550-556
93. Luo F.M., Liu X.J., Li S.Q., Wang Z.L., Liu C.T., and Yuan Y.M. Circulating ghrelin in patients with chronic obstructive pulmonary disease. Nutrition 21 (2005) 793-798
94. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 128 (2005) 1187-1193
95. American Thoracic Society. Official Statement, 1998. Dyspnea: mechanisms, assessment, and management; a consensus statement. Am J Respir Crit Care Med 159 (1999) 321-340
96. Nisar M., Earis J.E., Pearson M.G., et al. Acute bronchodilator trials in chronic obstructive pulmonary disease. Am Rev Respir Dis 133 (1986) 14-20
97. Ambrosino N., Giorgio M., and Di Paco A. Strategies to improve breathlessness and exercise tolerance in Chronic Obstructive Pulmonary Disease. Resp Med: COPD Update 2 (2006) 2-8
98. Poole P.J., Veale A.G., and Black P.N. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1877-1880
99. Abernethy A.P., Currow D.C., Frith P., Fazekas B.S., McHugh A., and Bui C. Randomized, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. Br Med J 327 (2003) 523-528
100. Zebraski S.E., Kochenash S.M., and Raffa R.B. Lung opioid receptors: pharmacology and possible target for nebulised morphine in dyspnea. Life Sci 66 (2000) 2221-2231
101. Luce J.M., and Luce J.A. Management of dyspnea in patients with far-advanced lung disease. J Am Mad Assoc 285 (2001) 1331-1337
102. Jennings A.L., Davies A.N., Higgins J.P.T., Gibbs J.S.R., and Broadley K.E. A systematic review of the use of opioids in the management of dyspnoea. Thorax 57 (2002) 939-944
103. Juan G., Ramón M.M.D., Carlos Valia J.C., Cortijo J., Rubio E., Morcillo E., et al. Palliative treatment of dyspnea with epidural methadone in advanced emphysema. Chest 128 (2005) 3322-3328
104. Woodcock A.A., Gross E.R., and Geddes D.M. Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J 283 (1981) 343-346
105. Man G.C.W., Hsu K., and Sproule B.J. Effect of alprazolam on exercise and dyspnoea in patients with chronic obstructive pulmonary disease. Chest 90 (1986) 832-836
106. Singh N.P., Despars J.A., Stansbury D.W., et al. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 103 (1993) 800-804
107. Ambrosino N., and Scano G. Measurement and treatment of dyspnoea. Respir Med 95 (2001) 539-547
108. Massod A.R., Reed J.W., and Thomas S.H. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax 50 (1995) 629-634
109. Stark R.D., O'Neill P.A., Russel N.J.W., Heapy C.G., and Stretton T.B. Effects of small particle aerosols of local anaesthetic on dyspnoea in patients with respiratory disease. Clin Sci 69 (1985) 29-36
110. Guz A., Noble N.I.M., Eisele I.H., and Trenchard D. Experimental results of vagal blockade in cardiopulmonary disease. In: Porter R. (Ed). Breathing: Hering-Breuer centenary symposium (1970), Churchill, London 315-329
111. Kimoff R.I., Chong T.T., Cosio M.G., Querraty A., and Levy R.D. Pulmonary denervation effects on dyspnoea and ventilatory pattern during exercise. Am Rev Respir Dis 142 (1990) 1034-1040
112. Ong K.C., Kor A.C., Chong W.F., Earnest A., and Wang Y.T. Effects of inhaled furosemide on exertional dyspnoea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169 (2004) 1028-1033
113. Palange P., Crimi E., Pellegrino R., and Brusasco V. Supplemental oxygen and heliox: 'new' tools for exercise training in chronic obstructive pulmonary disease. Curr Opin Pulm Med 11 (2005) 145-148
114. O'Donnell D.E., D'Arsigny C., and Webb K.A. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 892-898
115. Ambrosino N., Giannini D., and D'Amico I. How good is the evidence for ambulatory oxygen in chronic obstructive pulmonary disease. Chronic Respir Dis 3 (2004) 125-126
116. Emtner M., Porszasz J., Burns M., Somfay A., and Casaburi R. Benefits of supplemental oxygen in exercise training in non-hypoxemic COPD patients. Am J Respir Crit Care Med 68 (2003) 1034-1042
117. Palange P., Valli G., Onorati P., Antonucci R., Paoletti P., Rosato A., et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 97 (2004) 1637-1642
118. Laude E.A., Duffy N.C., Baveystock C., et al. The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease. A randomized crossover trial. Am J Respir Crit Care Med 173 (2006) 865-870
119. Eves N.D., Petersen S.R., Haykowsky M.J., Wong E.Y., and Jones R.L. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174 (2006) 763-771
120. Levy M., Tanios M.A., Nelson D., Short K., Senechia A., Vespia J., et al. Outcomes of patients with do-not-intubate orders treated with noninvasive ventilation. Crit Care Med 32 (2004) 2002-2007
121. Schettino G., Altobelli N., and Kacmarek R.M. Noninvasive positive pressure ventilation reverses acute respiratory failure in selected "do-not-intubate" patients. Crit Care Med 33 (2005) 1976-1982
122. Chu C- M., Chan V.L., Wong I.W.Y., Leung W., Lin A.W.N., and Cheung K.-F. Noninvasive ventilation in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease who refused endotracheal intubation. Crit Care Med 32 (2004) 372-377
123. Bott J., Carrol M.P., Conway J.H., Keity S.E.J., Ward E.M., Brown A.M., et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 341 (1993) 1555-1557
124. Cuomo A., Conti G., Delmastro M., Nava S., Antonelli M., Ceriana P., et al. Noninvasive mechanical ventilation as a palliative treatment of acute respiratory failure in patients with end-stage solid cancer. Palliat Med 18 (2004) 602-610
125. Antonelli Incalzi R., Gemma A., Marra C., Muzzolon R., Capparella O., and Carbonin P.U. Chronic obstructive pulmonary disease: an original model of cognitive decline. Am Rev Respir Dis 148 (1993) 418-424
126. Lacasse Y., Rousseau L., and Maltais M. Prevalence of depression symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 20 (2001) 80-86
127. Hopkins R.O., Weaver L.K., Collingridge D., Parkinson R.B., Chan K.J., and Orme Jr. J.F. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 171 (2005) 340-347
128. Ambrosino N., Bruletti G., Scala V., Porta R., and Vitacca M. Cognitive and perceived health status in patients recovering from an acute exacerbation of COPD. A controlled study. Intensive Care Med 28 (2002) 170-177
129. Peveler R., Carson A., and Rodin G. ABC of psychological medicine. Depression in medical patients. Br Med J 325 (2002) 149-152
130. Wagena E.J., Arrindell W.A., Wouters E.F.M., and van Schayck C.P. Are patients with COPD psychologically distressed?. Eur Respir J 26 (2005) 242-248
131. Van Manen J.G., Bindels P.J., Dekker F.W., Ljzermans C.J., van der Zee J.S., and Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 57 (2002) 412-416
132. Kunik M.E., Roundy K., Veazey C., Souchek J., Richardson P., Wray N.P., and Stanley M.A. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 127 (2005) 1205-1211
133. Crews W.D., Jefferson A.L., Bolduc T., Elliott J.B., Ferro N.M., Broshek D.K., et al. Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol 16 (2001) 643-652
134. Singer H.K., Ruchinskas R.A., Riley K.C., Broshek D.K., and Barth J.T. The psychological impact of end-stage lung disease. Chest 120 (2001) 1246-1252
135. Lacasse Y., Beaudoin L., Rousseau L., and Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 61 (2004) 140-147
136. Simonds A.K. Ethics and decision making in end stage lung disease. Thorax 58 (2003) 272-277
137. Mulcahy P., Buetow S., Osman L., Coster G., Bray Y., White P., et al. GPs' attitudes to discussing prognosis in severe COPD: an Auckland (NZ) to London (UK) comparison. Fam Pract 22 (2005) 538-540
138. Elkington H., White P., Addington-Hall J., Higgs R., and Edmonds P. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med 19 (2005) 485-491
139. McNeely P.D., Hebert P.C., Dales R.E., O'Connor A., Wells G., McKim D., et al. Deciding about mechanical ventilation in endstage chronic obstructive pulmonary disease: how respirologists perceive their role. Can Med Assoc J 156 (1997) 177-183
140. Fried T.R., Bradley E.H., Towle V.R., and Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med 346 (2002) 1061-1066
141. Dales R.E., O'Connor A., Hebert P., Sullivan K., McKim D., and Llewellyn-Thomas H. Intubation and mechanical ventilation for COPD. Development of an instrument to elicit patient preferences. Chest 116 (1999) 792-800
142. Pruchno R.A., Lemay E.P., Feild L., and Levinsky N.G. Spouse as Health Care Proxy for dialysis patients: whose preferences matter?. Gerontologist 45 (2005) 812-819
143. Hahn M.E. Advance directives and patient-physician communication. J Am Med Assoc 298 (2006) 1
144. Heffner J.E., Fahy B., Hilling L., and Barbieri C. Outcomes of advance directive education of pulmonary of pulmonary rehabilitation patients. Am J Respir Crit Care Med 155 (1997) 1055-1059
145. Curtis J.R., Wenrich M.D., Carline J.D., Shannon S.E., Ambrozy D.M., and Ramsey P.G. Patients' perspectives on physician skill in end-of-life care. Differences between patients with COPD, cancer and AIDS. Chest 122 (2002) 356-362
146. Knauft E., Nielsen E.L., Engelberg R.A., Patrick D.L., and Randall Curtis R. Barriers and facilitators to end-of life-care communication for patients with COPD. Chest 127 (2005) 2188-2196